Literature DB >> 8392298

Elevated platelet membrane phosphatidylinositol-4,5-bisphosphate in bipolar mania.

A S Brown1, A G Mallinger, L C Renbaum.   

Abstract

Membrane phospholipids were measured in platelets of seven medication-free patients in the manic phase of bipolar affective disorder and seven healthy comparison subjects. The relative percentage of platelet membrane phosphatidylinositol-4,5-bisphosphate was significantly higher in the manic patients than in the comparison subjects. These results are consistent with an enhanced neuronal second messenger response after 5-hydroxytryptamine receptor stimulation followed by neurotransmitter release.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392298     DOI: 10.1176/ajp.150.8.1252

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  5 in total

1.  Serum phosphatidylinositol as a biomarker for bipolar disorder liability.

Authors:  Emma Em Knowles; Peter J Meikle; Kevin Huynh; Harald Hh Göring; Rene L Olvera; Samuel R Mathias; Ravi Duggirala; Laura Almasy; John Blangero; Joanne E Curran; David C Glahn
Journal:  Bipolar Disord       Date:  2017-02-23       Impact factor: 6.744

Review 2.  Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder.

Authors:  Mark J Niciu; Dawn F Ionescu; Daniel C Mathews; Erica M Richards; Carlos A Zarate
Journal:  CNS Spectr       Date:  2013-03-11       Impact factor: 3.790

Review 3.  Molecular pharmacology in a simple model system: implicating MAP kinase and phosphoinositide signalling in bipolar disorder.

Authors:  Marthe H R Ludtmann; Katrina Boeckeler; Robin S B Williams
Journal:  Semin Cell Dev Biol       Date:  2010-11-18       Impact factor: 7.727

Review 4.  Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers.

Authors:  Jung Goo Lee; Young Sup Woo; Sung Woo Park; Dae-Hyun Seog; Mi Kyoung Seo; Won-Myong Bahk
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-05-31       Impact factor: 3.731

Review 5.  Insulin signaling as a therapeutic mechanism of lithium in bipolar disorder.

Authors:  Iain H Campbell; Harry Campbell; Daniel J Smith
Journal:  Transl Psychiatry       Date:  2022-08-29       Impact factor: 7.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.